Annual EBIT
-$175.94 M
-$65.05 M-58.66%
December 31, 2023
Summary
- As of February 8, 2025, BCYC annual earnings before interest & taxes is -$175.94 million, with the most recent change of -$65.05 million (-58.66%) on December 31, 2023.
- During the last 3 years, BCYC annual EBIT has fallen by -$124.67 million (-243.12%).
- BCYC annual EBIT is now -985.20% below its all-time high of -$16.21 million, reached on December 31, 2017.
Performance
BCYC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$54.22 M
-$15.34 M-39.47%
September 30, 2024
Summary
- As of February 8, 2025, BCYC quarterly earnings before interest & taxes is -$54.22 million, with the most recent change of -$15.34 million (-39.47%) on September 30, 2024.
- Over the past year, BCYC quarterly EBIT has dropped by -$15.34 million (-39.47%).
- BCYC quarterly EBIT is now -1752.31% below its all-time high of -$2.93 million, reached on March 31, 2018.
Performance
BCYC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$167.14 M
-$7.41 M-4.64%
September 30, 2024
Summary
- As of February 8, 2025, BCYC TTM earnings before interest & taxes is -$167.14 million, with the most recent change of -$7.41 million (-4.64%) on September 30, 2024.
- Over the past year, BCYC TTM EBIT has dropped by -$7.41 million (-4.64%).
- BCYC TTM EBIT is now -5610.32% below its all-time high of -$2.93 million, reached on March 31, 2018.
Performance
BCYC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BCYC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.7% | -39.5% | -4.6% |
| 3 y3 years | -243.1% | -39.5% | -4.6% |
| 5 y5 years | -691.0% | -39.5% | -4.6% |
BCYC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -168.6% | at low | -201.8% | at low | -155.2% | +5.0% |
| 5 y | 5-year | -470.1% | at low | -481.3% | at low | -441.6% | +5.0% |
| alltime | all time | -985.2% | at low | -1752.3% | at low | -5610.3% | +5.0% |
Bicycle Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$54.22 M(+39.5%) | -$167.14 M(+4.6%) |
| Jun 2024 | - | -$38.87 M(+49.0%) | -$159.74 M(-2.1%) |
| Mar 2024 | - | -$26.09 M(-45.6%) | -$163.16 M(-7.3%) |
| Dec 2023 | -$175.94 M(+58.7%) | -$47.96 M(+2.5%) | -$175.94 M(+11.7%) |
| Sep 2023 | - | -$46.81 M(+10.7%) | -$157.56 M(+13.7%) |
| Jun 2023 | - | -$42.30 M(+8.8%) | -$138.51 M(+13.0%) |
| Mar 2023 | - | -$38.87 M(+31.5%) | -$122.61 M(+10.6%) |
| Dec 2022 | -$110.90 M(+69.3%) | -$29.57 M(+6.5%) | -$110.90 M(+11.7%) |
| Sep 2022 | - | -$27.77 M(+5.2%) | -$99.29 M(+15.7%) |
| Jun 2022 | - | -$26.39 M(-2.8%) | -$85.79 M(+11.9%) |
| Mar 2022 | - | -$27.16 M(+51.2%) | -$76.65 M(+17.0%) |
| Dec 2021 | -$65.50 M | -$17.96 M(+25.9%) | -$65.50 M(+1.4%) |
| Sep 2021 | - | -$14.27 M(-17.3%) | -$64.56 M(+6.0%) |
| Jun 2021 | - | -$17.25 M(+7.8%) | -$60.90 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.01 M(-6.0%) | -$55.86 M(+8.9%) |
| Dec 2020 | -$51.28 M(+66.1%) | -$17.03 M(+60.6%) | -$51.28 M(+17.7%) |
| Sep 2020 | - | -$10.60 M(-13.2%) | -$43.57 M(+0.8%) |
| Jun 2020 | - | -$12.21 M(+6.8%) | -$43.22 M(+10.8%) |
| Mar 2020 | - | -$11.43 M(+22.6%) | -$39.00 M(+26.4%) |
| Dec 2019 | -$30.86 M(+38.8%) | -$9.33 M(-9.0%) | -$30.86 M(+4.4%) |
| Sep 2019 | - | -$10.25 M(+28.4%) | -$29.57 M(+15.2%) |
| Jun 2019 | - | -$7.99 M(+142.5%) | -$25.68 M(+13.4%) |
| Mar 2019 | - | -$3.29 M(-59.0%) | -$22.65 M(+1.6%) |
| Dec 2018 | -$22.24 M(+37.2%) | -$8.04 M(+26.4%) | -$22.28 M(+56.4%) |
| Sep 2018 | - | -$6.36 M(+28.2%) | -$14.24 M(+80.6%) |
| Jun 2018 | - | -$4.96 M(+69.4%) | -$7.88 M(+169.4%) |
| Mar 2018 | - | -$2.93 M | -$2.93 M |
| Dec 2017 | -$16.21 M | - | - |
FAQ
- What is Bicycle Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual EBIT year-on-year change?
- What is Bicycle Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly EBIT year-on-year change?
- What is Bicycle Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM EBIT year-on-year change?
What is Bicycle Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BCYC is -$175.94 M
What is the all time high annual EBIT for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual earnings before interest & taxes is -$16.21 M
What is Bicycle Therapeutics annual EBIT year-on-year change?
Over the past year, BCYC annual earnings before interest & taxes has changed by -$65.05 M (-58.66%)
What is Bicycle Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BCYC is -$54.22 M
What is the all time high quarterly EBIT for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly earnings before interest & taxes is -$2.93 M
What is Bicycle Therapeutics quarterly EBIT year-on-year change?
Over the past year, BCYC quarterly earnings before interest & taxes has changed by -$15.34 M (-39.47%)
What is Bicycle Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BCYC is -$167.14 M
What is the all time high TTM EBIT for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM earnings before interest & taxes is -$2.93 M
What is Bicycle Therapeutics TTM EBIT year-on-year change?
Over the past year, BCYC TTM earnings before interest & taxes has changed by -$7.41 M (-4.64%)